Patent Oppositions in vaccines and immunity drugs industry

Explore the competitive field of vaccines and immunity drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in vaccines and immunity drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the vaccines and immunity drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the vaccines and immunity drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE USA REPRESENTED BY THE SECRETARYDec 31, 2025BOULT WADE TENNANT
Antibody Compositions And Methods Of Use ThereofBRISTOL MYERS SQUIBBDec 22, 2025PAJARO
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 19, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Combinations Of Cabozantinib And Atezolizumab To Treat CancerEXELIXISDec 19, 2025STADA ARZNEIMITTEL
Antibody Compositions And Methods Of Use ThereofBRISTOL MYERS SQUIBBDec 19, 2025CAMULON
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 18, 2025KARO
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025ADVANZ PHARMA SERVICES UK
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 17, 2025BRAND MURRAY FULLER
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 15, 2025STRAWMAN
Anti-Pd-L1 Antibodies And Their Use To Enhance T-Cell FunctionROCHENov 28, 2025SANDOZ

To stay ahead in the competitive vaccines and immunity drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the vaccines and immunity drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Feb 12, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLUDWIG MAXIMILIANS UNIVERSITT MNCHEN10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentOSAKA UNIVERSITY10
Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
Sep 11, 2019Binding Molecules For Bcma And Cd3BOEHRINGER INGELHEIM8
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALS7
Jan 3, 2024Method For Producing Rna CompositionsCUREVAC MANUFACTURING7
Aug 21, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH7
Feb 26, 2020Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIA7
Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHME7